Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation.

Archives of pharmacal research - 1 Aug 1999

Kim K D, Kim J K, Kim S J, Choe I S, Chung T H, Choe Y K, Lim J S

Abstract excerpt

Dendritic cells (DCs) are potent professional antigen-presenting cells (APC) capable of inducing the primary T cell response to antigen. Although tumor cells express target antigens, they are incapable of stimulating a tumor-specific immune response due to a defect in the costimulatory signal tha...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neoplasm
Share to Antigens, Neoplasm
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coculture Techniques

Share to Cytotoxicity Tests, Immunologic

Share to Dendrites

Share to Indicators and Reagents

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 10489871
DOI: 10.1007/BF02979055

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10489871-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation.PMID 10489871Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.Semantic proximity Read ↗

Dendritic-Tumor Fusion Cell-Based Cancer VaccinesSemantic proximity Read ↗

Dendritic Cells and Their Role in Immunotherapy.Semantic proximity Read ↗

Immune system versus tumor: shifting the balance in favor of DCs and effective immunity.Semantic proximity Read ↗

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.Semantic proximity Read ↗

Cellular Immunotherapy with Dendritic Cells in Cancer: Current StatusSemantic proximity Read ↗

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read ↗

Dendritic Cells in the Cancer MicroenvironmentSemantic proximity Read ↗

Tumor-infiltrating dendritic cells in cancer pathogenesis.Semantic proximity Read ↗

Active immunization against cancer with dendritic cells: the near future.Semantic proximity Read ↗

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.